Steve Pollitt
Corporate Officer/Principal at Trinity Biosystems, Inc.
Profile
Dr. Steve Pollitt is Vice President-Process Sciences at Trinity Biosystems, Inc. and a Member at Sand Hill Angels, Inc.
Dr. Pollitt was previously employed as a Professor by University of Medicine & Dentistry of New Jersey.
He received his undergraduate degree from the University of Georgia and a doctorate degree from Purdue University.
Steve Pollitt active positions
Companies | Position | Start |
---|---|---|
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 2009-09-17 |
Former positions of Steve Pollitt
Companies | Position | End |
---|---|---|
University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
Training of Steve Pollitt
Purdue University | Doctorate Degree |
University of Georgia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Steve Pollitt